Uterine sarcoma Part II-Uterine endometrial stromal sarcoma: The TAG systematic review. 2016

Huann-Cheng Horng, and Kuo-Chang Wen, and Peng-Hui Wang, and Yi-Jen Chen, and Ming-Shyen Yen, and Heung-Tat Ng, and
Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Obstetrics and Gynecology, National Yang-Ming University School of Medicine, Taipei, Taiwan.

Endometrial stromal tumors are rare uterine tumors (<1%). Four main categories include endometrial stromal nodule, low-grade endometrial stromal sarcoma (LG-ESS), high-grade endometrial stromal sarcoma (HG-ESS), and uterine undifferentiated sarcoma (UUS). This review is a series of articles discussing the uterine sarcomas. LG-ESS, a hormone-dependent tumor harboring chromosomal rearrangement, is an indolent tumor with a favorable prognosis, but characterized by late recurrences even in patients with Stage I disease, suggesting the requirement of a long-term follow-up. Patients with HG-ESS, based on the identification of YWHAE-NUTM2A/B (YWHAE-FAM22A/B) gene fusion, typically present with advanced stage diseases and frequently have recurrences, usually within a few years after initial surgery. UUS is, a high-grade sarcoma, extremely rare, lacking a specific line of differentiation, which is a diagnosis of exclusion (the wastebasket category, which fails to fulfill the morphological and immunohistochemical criteria of translocation-positive ESS). Surgery is the main strategy in the management of uterine sarcoma. Due to rarity, complex biological characteristics, and unknown etiology and risk factors of uterine sarcomas, the role of adjuvant therapy is not clear. Only LG-ESS might respond to progestins or aromatase inhibitors.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D016889 Endometrial Neoplasms Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells. Cancer of Endometrium,Endometrial Cancer,Endometrial Carcinoma,Cancer of the Endometrium,Carcinoma of Endometrium,Endometrium Cancer,Neoplasms, Endometrial,Cancer, Endometrial,Cancer, Endometrium,Cancers, Endometrial,Cancers, Endometrium,Carcinoma, Endometrial,Carcinomas, Endometrial,Endometrial Cancers,Endometrial Carcinomas,Endometrial Neoplasm,Endometrium Cancers,Endometrium Carcinoma,Endometrium Carcinomas,Neoplasm, Endometrial
D060787 Neoplasm Grading Methods which attempt to express in replicable terms the level of CELL DIFFERENTIATION in neoplasms as increasing ANAPLASIA correlates with the aggressiveness of the neoplasm. Gleason Grading,Gleason Score,Tumor Grading,Grading, Gleason,Grading, Neoplasm,Grading, Tumor,Score, Gleason
D018203 Sarcoma, Endometrial Stromal A highly malignant subset of neoplasms arising from the endometrial stroma. Tumors in this group infiltrate the stroma with a wide range of atypia cells and numerous mitoses. They are capable of widespread metastases (NEOPLASM METASTASIS). Endometrial Stromal Sarcoma,Endometrial Stromal Sarcomas,Sarcomas, Endometrial Stromal,Stromal Sarcoma, Endometrial,Stromal Sarcomas, Endometrial

Related Publications

Huann-Cheng Horng, and Kuo-Chang Wen, and Peng-Hui Wang, and Yi-Jen Chen, and Ming-Shyen Yen, and Heung-Tat Ng, and
September 2013, Obstetrics and gynecology,
Huann-Cheng Horng, and Kuo-Chang Wen, and Peng-Hui Wang, and Yi-Jen Chen, and Ming-Shyen Yen, and Heung-Tat Ng, and
October 2016, Taiwanese journal of obstetrics & gynecology,
Huann-Cheng Horng, and Kuo-Chang Wen, and Peng-Hui Wang, and Yi-Jen Chen, and Ming-Shyen Yen, and Heung-Tat Ng, and
January 1994, Revista chilena de obstetricia y ginecologia,
Huann-Cheng Horng, and Kuo-Chang Wen, and Peng-Hui Wang, and Yi-Jen Chen, and Ming-Shyen Yen, and Heung-Tat Ng, and
November 2020, The journal of obstetrics and gynaecology research,
Huann-Cheng Horng, and Kuo-Chang Wen, and Peng-Hui Wang, and Yi-Jen Chen, and Ming-Shyen Yen, and Heung-Tat Ng, and
July 1999, Journal of clinical pathology,
Huann-Cheng Horng, and Kuo-Chang Wen, and Peng-Hui Wang, and Yi-Jen Chen, and Ming-Shyen Yen, and Heung-Tat Ng, and
September 2016, Journal of radiology case reports,
Huann-Cheng Horng, and Kuo-Chang Wen, and Peng-Hui Wang, and Yi-Jen Chen, and Ming-Shyen Yen, and Heung-Tat Ng, and
January 2006, Korean journal of radiology,
Huann-Cheng Horng, and Kuo-Chang Wen, and Peng-Hui Wang, and Yi-Jen Chen, and Ming-Shyen Yen, and Heung-Tat Ng, and
June 2014, Annals of diagnostic pathology,
Huann-Cheng Horng, and Kuo-Chang Wen, and Peng-Hui Wang, and Yi-Jen Chen, and Ming-Shyen Yen, and Heung-Tat Ng, and
March 1964, Scottish medical journal,
Huann-Cheng Horng, and Kuo-Chang Wen, and Peng-Hui Wang, and Yi-Jen Chen, and Ming-Shyen Yen, and Heung-Tat Ng, and
January 2011, Acta medica Iranica,
Copied contents to your clipboard!